Sweden: BioArctic names Martin-Löf as new CFO as Mattsson steps down

BioArctic, a biopharma company focusing on disease-modifying treatments for neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and ALS, has named Anders Martin-Löf as its new CFO. He replaces current CFO Jan Mattsson, who will remain in his role until Martin-Löf takes up his position on June 1 at the latest. Mattsson will then move…

You must be a HMI Subscriber to view this content.

Subscribe Now »